CoChat

Incretin Receptors in Non-Neoplastic and Neoplastic Thyroid C Cells in Rodents and Humans: Relevance for Incretin-Based Diabetes Therapy

Open access

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

While incretins are of great interest for the therapy of diabetes 2, the focus has recently been brought to the thyroid, since rodents treated with glucagon-like peptide-1 (GLP-1) analogs were found to occasionally develop medullary thyroid carcinomas. Incretin receptors for GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) were therefore measured in various rodent and human thyroid conditions. In vitroGLP-1 and GIP receptor autoradiography were performed in normal thyroids, C-cell hyperplasia and medullary thyroid carcinomas in rodents. Receptor incidence and density were assessed and compared with the receptor expression in human thyroids, medullary thyroid carcinomas, and TT cells. GLP-1 receptors are expressed in C cells of normal rat and mice thyroids. Their density is markedly increased in rat C-cell hyperplasia and medullary thyroid carcinomas, where their incidence amounts to 100%. GIP receptors are neither detected in normal rodent thyroids nor in C-cell hyperplasia, but are present in all rat medullary thyroid carcinomas. No GLP-1 or GIP receptors are detected in normal human thyroids. Whereas only 27% of all human medullary thyroid carcinomas express GLP-1 receptors, up to 89% express GIP receptors in a high density. TT cells lack GLP-1 receptors but express GIP receptors. GLP-1 receptors are frequently expressed in non-neoplastic and neoplastic C cells in rodents while they are rarely detected in human C-cell neoplasia, suggesting species differences. Conversely, GIP receptors appear to be massively overexpressed in neoplastic C cells in both species. The presence of incretin receptors in thyroid C cell lesions suggests that this organ should be monitored before and during incretin-based therapy of diabetes.

Overview

Integrity signals

Registry

Crossref · 10.1159/000330447

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 21 references

Research works printed but not linked: 1

  1. 10.1002%2F%28SICI%291097-0215%2819960904%2967%3A5%3C644%3A%3AAID-IJC9%3E3.0.CO%3B2-U · doi:10.1002/(sici)1097-0215(19960904)67:5<644::aid-ijc9>3.0.co;2-u

Cited by

See all 80

Metadata

Authors
Waser, B., Beetschen, K., Pellegata, N. S., & Reubi, J. C.
Affiliations
  • University of Bern (CH)
  • Helmholtz Munich (DE)
Venue
Neuroendocrinology
Publisher
S. Karger AG
Published
2011
Volume
94
Issue
4
Pages
291-301
ISSN
  • 0028-3835 (ISSN-L)
  • 1423-0194
OpenAlex
W2078709678
Cited by
80
References
20
Citations by year
2026: 7 · 2025: 4 · 2024: 4 · 2023: 3 · 2022: 6 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 5 · 2016: 5 · 2015: 7 · 2014: 9 · 2013: 9 · 2012: 7
FWCI
7.60
Type
journal article
Language
en
Open access
Licence
Locations
  • Neuroendocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • Bern Open Repository and Information System (University of Bern) (submittedVersion, other-oa)
  • Site cant be reached (submittedVersion)
  • Open Access CRIS of the University of Bern
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
incretin receptors, GLP-1 receptor, GIP receptor, medullary thyroid carcinoma, C cells, C-cell hyperplasia, TT cells, type 2 diabetes treatment, species differences, receptor density, thyroid function monitoring
MeSH terms
Glucagon-Like Peptide-1 Receptor, Animals, Cells, Cultured, Diabetes Mellitus, Type 2, Humans, Mice, Inbred BALB C, Mice, Inbred C57BL, Receptors, Gastrointestinal Hormone, Thyroid Gland, Thyroid Neoplasms, Tumor Cells, Cultured, Rats, Sprague-Dawley, Rats, Wistar, Receptors, Glucagon, Carcinoma, Neuroendocrine, Mice, Rats, Incretins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Incretin Receptors in Non-Neoplastic and Neoplastic Thyroid C Cells in Rodents and Humans: Relevance for Incretin-Based Diabetes Therapy. https://app.cochat.ai/papers/10.1159/000330447
The paper
Waser, B., Beetschen, K., Pellegata, N. S., & Reubi, J. C. (2011). Incretin Receptors in Non-Neoplastic and Neoplastic Thyroid C Cells in Rodents and Humans: Relevance for Incretin-Based Diabetes Therapy. Neuroendocrinology. https://doi.org/10.1159/000330447

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.